News & Updates

Show Multimedia Only
Metabolic surgery bests medical/lifestyle management for people with diabetes in the long run

Metabolic surgery bests medical/lifestyle management for people with diabetes in the long run

21 Jul 2023 byJairia Dela Cruz

Individuals with type 2 diabetes (T2D) may fare better with metabolic bariatric surgery, which confers more favourable long-term outcomes as compared with intensive medical and lifestyle management, based on the 7- and 12-year data from the ARMMS-T2D* trial.

21 Jul 2023
Age, tumour size predict post-TACE complications in HCC patients

Age, tumour size predict post-TACE complications in HCC patients

21 Jul 2023 byStephen Padilla

In patients with hepatocellular carcinoma (HCC), most complications following transarterial chemoembolization (TACE) involve minor postembolization syndrome, reveals a study presented at EASL 2023. The incidence of major complications is high at 25 percent, with a 1.8-percent death rate.

21 Jul 2023
Advanced liver fibrosis a red flag for poor outcomes in T2D

Advanced liver fibrosis a red flag for poor outcomes in T2D

18 Jul 2023

Among individuals with type 2 diabetes (T2D), the risk of poor outcomes such as heart failure and hospitalizations is high in the presence of advanced liver fibrosis, according to a study.

18 Jul 2023
‘Triple-G’ obesity drug also targets NAFLD in phase II trial

‘Triple-G’ obesity drug also targets NAFLD in phase II trial

11 Jul 2023 byAudrey Abella

In a subanalysis of a phase II trial on obesity, retatrutide, a triagonist of GIP*, GLP**, and glucagon receptors, also demonstrated multiple favourable signals for nonalcoholic fatty liver disease (NAFLD).

11 Jul 2023